Your browser doesn't support javascript.
loading
What doesn't fit is made to fit: Pim-1 kinase adapts to the configuration of stilbene-based inhibitors.
Hochban, Phil M M; Heyder, Lukas; Heine, Andreas; Diederich, Wibke E.
Afiliação
  • Hochban PMM; Institut für Pharmazeutische Chemie, Zentrum für Tumor und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.
  • Heyder L; Institut für Pharmazeutische Chemie, Zentrum für Tumor und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.
  • Heine A; Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.
  • Diederich WE; Institut für Pharmazeutische Chemie, Zentrum für Tumor und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.
Arch Pharm (Weinheim) ; 357(6): e2400094, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38631036
ABSTRACT
Recently, we have developed novel Pim-1 kinase inhibitors starting from a dihydrobenzofuran core structure using a computational approach. Here, we report the design and synthesis of stilbene-based Pim-1 kinase inhibitors obtained by formal elimination of the dihydrofuran ring. These inhibitors of the first design cycle, which were obtained as inseparable cis/trans mixtures, showed affinities in the low single-digit micromolar range. To be able to further optimize these compounds in a structure-based fashion, we determined the X-ray structures of the protein-ligand-complexes. Surprisingly, only the cis-isomer binds upon crystallization of the cis/trans-mixture of the ligands with Pim-1 kinase and the substrate PIMTIDE, the binding mode being largely consistent with that predicted by docking. After crystallization of the exclusively trans-configured derivatives, a markedly different binding mode for the inhibitor and a concomitant rearrangement of the glycine-rich loop is observed, resulting in the ligand being deeply buried in the binding pocket.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estilbenos / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-pim-1 Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estilbenos / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-pim-1 Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Alemanha